Potassium phosphate and Dyspnea exacerbated - a phase IV clinical study of FDA data

Summary:

Dyspnea exacerbated is reported as a side effect among people who take Potassium phosphate (potassium), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Pantoprazole, and have Primary pulmonary hypertension.

The phase IV clinical study analyzes which people have Dyspnea exacerbated when taking Potassium phosphate. It is created by eHealthMe based on reports of 571 people who have side effects when taking Potassium phosphate from the FDA, and is updated regularly.

What is Potassium phosphate?

Potassium phosphate has active ingredients of potassium. eHealthMe is studying from 578 Potassium phosphate users. Check the latest studies of Potassium phosphate.

What is Dyspnea exacerbated?

Dyspnea exacerbated is found to be associated with 3,341 drugs and 1,659 conditions by eHealthMe. Check the latest studies of Dyspnea exacerbated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

571 people reported to have side effects when taking Potassium phosphate.
Among them, 28 people (4.9%) have Dyspnea exacerbated.

Could Potassium phosphate cause Dyspnea exacerbated?

Among these 28 people:

How long have people been on Potassium phosphate when they have Dyspnea exacerbated? *

What is the gender of people who have Dyspnea exacerbated when taking Potassium phosphate? *

female: 67.86 %
male: 32.14 %

What is the age of people who have Dyspnea exacerbated when taking Potassium phosphate? *

What are other drugs people take besides Potassium phosphate? *

What are other side effects people have besides Dyspnea exacerbated? *

Diarrhea: 12 people, 42.86%
Arrhythmias (irregular heartbeat): 11 people, 39.29%
Fever: 9 people, 32.14%
Anaemia (lack of blood): 7 people, 25.00%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 21.43%
Pneumonia: 6 people, 21.43%
Loss Of Consciousness: 6 people, 21.43%
Urinary Tract Infection: 6 people, 21.43%
Fatigue (feeling of tiredness): 6 people, 21.43%
Pleural Effusion (water on the lungs): 6 people, 21.43%

What are the existing conditions these people have? *

Hypokalemia (low potassium): 7 people, 25.00%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 7 people, 25.00%
Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood): 6 people, 21.43%
Lung Cancer - Non-Small Cell (lung cancer): 3 people, 10.71%
Pain: 3 people, 10.71%
Agitation (state of anxiety or nervous excitement): 3 people, 10.71%
Insomnia (sleeplessness): 3 people, 10.71%
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 3 people, 10.71%
Diffuse Large B-Cell Lymphoma Stage Iv (cancer of b cells, a type of white blood cell-stage iv): 3 people, 10.71%
Constipation: 3 people, 10.71%

* Approximation only. Some reports may have incomplete information.

Do you take Potassium phosphate and have Dyspnea exacerbated?

- Check whether Dyspnea exacerbated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Potassium phosphate:

Potassium phosphate (578 reports)

Browse all side effects of Potassium phosphate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dyspnea exacerbated:

Dyspnea exacerbated (3,341 drugs)

Browse all the conditions that are associated with Dyspnea exacerbated:

Dyspnea exacerbated (1,659 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on potassium (the active ingredients of Potassium phosphate) and Potassium phosphate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.